Boardroom Alpha
Boardroom Alpha
EBC · Current Report (Form 8-K) · Filed October 23, 2025

Eastern Bankshares Inc — Current Report (Form 8-K)

Form
8-K
Filed
October 23, 2025
Period
Oct 23, 2025
Ticker
EBC
Accession
0001628280-25-046111
Boardroom Alpha · Filing insights

Eastern Bankshares reports Q3 2025 earnings; approves $0.13 quarterly dividend and up to 11.9 million share repurchase (5%); Fed non-objection.

Buyback authorized
About Eastern Bankshares Inc
Market cap
$4.6B
1Y TSR
+36.1%
3Y TSR
+20.4%
Board grade
C
Sector
Financial Services
CEO
Denis K Sheahan
Last annual meeting: May 18, 2026 · View full Eastern Bankshares Inc profile →
ebc-20251023

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): October 23, 2025
EASTERN BANKSHARES, INC.
(Exact Name of Registrant as Specified in Charter)
 
Massachusetts 001-39610 84-4199750
(State or Other Jurisdiction
of Incorporation or Organization)
 (Commission
File Number)
 (I.R.S. Employer
Identification No.)
125 High Street 02110
Boston, MA
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (800) 327-8376
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class  Trading
Symbol(s)
  Name of each exchange
on which registered
Common Stock  EBC  Nasdaq Global Select Market
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



Item 2.02    Results of Operations and Financial Condition.

On October 23, 2025, Eastern Bankshares, Inc., a Massachusetts corporation (the “Company”) and the stock holding company for Eastern Bank, issued a press release in which it announced its earnings for the quarter ended September 30, 2025. A copy of the press release is furnished herewith as Exhibit 99.1.

Item 7.01    Regulation FD Disclosure.

In the press release announcing the Company's earnings for the quarter ended September 30, 2025, the Company announced the approval by its Board of Directors of a regular quarterly cash dividend of $0.13 per share payable on December 15, 2025 to shareholders of record as of the close of business on December 3, 2025.

In connection with issuing such press release, the Company posted an investor presentation in the “Presentations” section of the Company’s investor relations website at investor.easternbank.com on October 23, 2025.

Item 8.01    Other Events.

In the press release announcing the Company's earnings for the quarter ended September 30, 2025, the Company also announced that its Board of Directors has approved a new share repurchase program that authorizes the Company to purchase up to 11.9 million shares, or 5% of the Company’s outstanding shares of common stock as of November 1, 2025 over a 12-month period. The purchases may occur in open market or privately negotiated transactions.

On October 15, 2025, the Company received notice of non-objection from the Board of Governors of the Federal Reserve System for the share repurchase program.


Item 9.01    Financial Statements and Exhibits.
(d)Exhibits
ExhibitDescription
99.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
EASTERN BANKSHARES, INC.
DATE: October 23, 2025
By: /s/ David Rosato
 David Rosato
 Chief Financial Officer


From this filing to the watchlist

Catch material events the day they file.

Boardroom Alpha's monitors flag CEO/CFO transitions, restatements, going-concern risk, auditor changes, and 8-K events the day they hit EDGAR — across 6,000+ U.S. public companies. Daily digest by watchlist, API-accessible.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Eastern Bankshares Inc (EBC)

Reference

Frequently asked questions

When did Eastern Bankshares Inc file this 8-K?
Eastern Bankshares Inc (EBC) filed this Current Report (Form 8-K) with the SEC on October 23, 2025. The accession number assigned by EDGAR is 0001628280-25-046111.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Eastern Bankshares reports Q3 2025 earnings; approves $0.13 quarterly dividend and up to 11.9 million share repurchase (5%); Fed non-objection. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Buyback authorized". It appears above the filing body as a labeled pill.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Eastern Bankshares Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Eastern Bankshares Inc has filed under CIK 1810546, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer